Dyax to present an update of its clinical development programs

Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Fourth Annual JMP Securities Healthcare Focus Conference, being held October 5-6^th at The New York Palace Hotel in New York City, NY. Mr. Christensen will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax presentation is scheduled for Monday, October 5^th at 1:00 PM (ET).

The Dyax presentation will be webcast live and may be accessed by visiting the Investor Relations section of the company website. The 25-minute presentation will also be available on the Dyax website for a limited period of time following the conference.